Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

ClearPoint Neuro Inc. - Common Stock (NQ:CLPT)

10.71 +0.24 (+2.33%)
Streaming Delayed Price Updated: 1:30 PM EDT, Sep 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 119,488
Open 10.56
Bid (Size) 10.71 (3)
Ask (Size) 10.76 (4)
Prev. Close 10.47
Today's Range 10.33 - 10.79
52wk Range 9.760 - 19.22
Shares Outstanding 23,639,616
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
ClearPoint Neuro Announces FDA Clearance Expanding Compatibility of the ClearPoint Prism Neuro Laser Therapy System with 1.5T MRI Scanners
Via ACCESS Newswire
ClearPoint Neuro Inc (NASDAQ:CLPT) Reports Mixed Q2 2025 Results with Record Revenue but Narrow EPS Miss
ClearPoint Neuro posts record Q2 2025 revenue of $9.2M (+17% YoY) but misses estimates. EPS at -$0.21. Stock rises slightly as company reaffirms full-year guidance amid strategic expansion. 
Via Chartmill

Performance

YTD
-31.1%
-31.1%
1 Month
-4.5%
-4.5%
3 Month
-7.6%
-7.6%
6 Month
-21.2%
-21.2%
1 Year
-13.6%
-13.6%

More News

Read More
ClearPoint Neuro Reports Second Quarter 2025 Results
Via ACCESS Newswire
ClearPoint Neuro Announces Progression of Key Partner Milestones throughout the Global Biologics and Drug Delivery Portfolio
Via ACCESS Newswire
ClearPoint Neuro to Announce Second Quarter 2025 Results August 12, 2025
Via ACCESS Newswire
ClearPoint Neuro Reports Fourth Quarter and Full Year 2024 Results
Via ACCESS Newswire
Earnings Scheduled For February 26, 2025
Via Benzinga
ClearPoint Neuro Announces FDA De Novo Marketing Authorization of SmartFlow Cannula for Direct Delivery of Gene Therapy to the Brain
Via ACCESSWIRE
Earnings Scheduled For August 12, 2025
Via Benzinga
ClearPoint Neuro Reports Q1 Earnings: Revenue Beat, EPS Miss, Company Affirms FY25 Guidance
Via Benzinga
ClearPoint Neuro Reports First Quarter 2025 Results
Via ACCESS Newswire
ClearPoint Neuro Announces Investment of up to $110 Million by Oberland Capital with $33.5 Million Funded at Closing
Via ACCESS Newswire
ClearPoint Neuro, Together with its Partner Clinical Laserthermia Systems, Announces FDA Submission to Expand the Labeling of ClearPoint Prism(R) to Include 1.5 T MRI
Via ACCESS Newswire
ClearPoint Neuro to Announce First Quarter 2025 Results May 13, 2025
Via ACCESS Newswire
ClearPoint Neuro Reports Third Quarter 2024 Results
Via ACCESSWIRE
ClearPoint Neuro to Participate in Multiple Global Healthcare Conferences in the Fourth Quarter of 2024
Via ACCESSWIRE
Earnings Scheduled For May 13, 2025
Via Benzinga
ClearPoint Neuro Announces Full Market Release of ClearPoint Navigation Software Version 3.0 – Delivering the First End-to-End ClearPoint Navigation Solution to the Operating Room
Via ACCESS Newswire
uniQure, Hertz Global, Eli Lilly And Other Big Stocks Moving Higher On Thursday
Via Benzinga
ClearPoint Neuro to Announce Fourth Quarter and Full Year 2024 Results February 26, 2025
Via ACCESS Newswire
ClearPoint Neuro Announces EU MDR Certification for the SmartFlow Cannula
Via ACCESS Newswire
ClearPoint Neuro Announces FDA Clearance for ClearPoint Navigation Software Version 3.0
Via ACCESS Newswire
Autoliv Posts Strong Sales, Joins United States Cellular, Netflix, Intuitive Surgical And Other Big Stocks Moving Higher On Friday
Via Benzinga
Hain Celestial Posts Upbeat Q4 Earnings, Joins Soleno Therapeutics, Energizer Holdings And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
CLPT Stock Earnings: ClearPoint Neuro Beats EPS, Beats Revenue for Q2 2024
Via InvestorPlace

Frequently Asked Questions

Is ClearPoint Neuro Inc. - Common Stock publicly traded?
Yes, ClearPoint Neuro Inc. - Common Stock is publicly traded.
What exchange does ClearPoint Neuro Inc. - Common Stock trade on?
ClearPoint Neuro Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for ClearPoint Neuro Inc. - Common Stock?
The ticker symbol for ClearPoint Neuro Inc. - Common Stock is CLPT on the Nasdaq Stock Market
What is the current price of ClearPoint Neuro Inc. - Common Stock?
The current price of ClearPoint Neuro Inc. - Common Stock is 10.71
When was ClearPoint Neuro Inc. - Common Stock last traded?
The last trade of ClearPoint Neuro Inc. - Common Stock was at 09/16/25 01:30 PM ET
What is the market capitalization of ClearPoint Neuro Inc. - Common Stock?
The market capitalization of ClearPoint Neuro Inc. - Common Stock is 253.27M
How many shares of ClearPoint Neuro Inc. - Common Stock are outstanding?
ClearPoint Neuro Inc. - Common Stock has 253M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.